Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1972 1
1973 1
1974 2
1976 1
1977 4
1978 1
1979 1
1981 7
1982 4
1983 8
1984 13
1985 3
1986 5
1987 4
1988 4
1990 4
1991 1
1992 2
1993 2
1994 1
1995 8
1996 3
1997 6
1998 2
1999 3
2000 1
2001 4
2003 3
2004 1
2006 1
2007 4
2008 2
2009 2
2010 1
2011 3
2012 3
2013 4
2014 3
2015 11
2016 6
2017 7
2018 12
2019 6
2020 22
2021 22
2022 12
2023 2
2024 6
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

220 results

Results by year

Filters applied: . Clear all
Page 1
IL-23 past, present, and future: a roadmap to advancing IL-23 science and therapy.
Krueger JG, Eyerich K, Kuchroo VK, Ritchlin CT, Abreu MT, Elloso MM, Fourie A, Fakharzadeh S, Sherlock JP, Yang YW, Cua DJ, McInnes IB. Krueger JG, et al. Among authors: sherlock jp. Front Immunol. 2024 Apr 15;15:1331217. doi: 10.3389/fimmu.2024.1331217. eCollection 2024. Front Immunol. 2024. PMID: 38686385 Free PMC article. Review.
Interleukin-23 in perspective.
Sherlock JP, Cua DJ. Sherlock JP, et al. Rheumatology (Oxford). 2021 Oct 19;60(Suppl 4):iv1-iv3. doi: 10.1093/rheumatology/keab461. Rheumatology (Oxford). 2021. PMID: 34668016 Free PMC article. No abstract available.
JNJ-77242113, a highly potent, selective peptide targeting the IL-23 receptor, provides robust IL-23 pathway inhibition upon oral dosing in rats and humans.
Fourie AM, Cheng X, Chang L, Greving C, Li X, Knight B, Polidori D, Patrick A, Bains T, Steele R, Allen SJ, Patch RJ, Sun C, Somani S, Bhandari A, Liu D, Huie K, Li S, Rodriguez MA, Xue X, Kannan A, Kosoglou T, Sherlock JP, Towne J, Holland MC, Modi NB. Fourie AM, et al. Among authors: sherlock jp. Sci Rep. 2024 Jul 30;14(1):17515. doi: 10.1038/s41598-024-67371-5. Sci Rep. 2024. PMID: 39080319 Free PMC article.
The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.
IST-3 collaborative group; Sandercock P, Wardlaw JM, Lindley RI, Dennis M, Cohen G, Murray G, Innes K, Venables G, Czlonkowska A, Kobayashi A, Ricci S, Murray V, Berge E, Slot KB, Hankey GJ, Correia M, Peeters A, Matz K, Lyrer P, Gubitz G, Phillips SJ, Arauz A. IST-3 collaborative group, et al. Lancet. 2012 Jun 23;379(9834):2352-63. doi: 10.1016/S0140-6736(12)60768-5. Epub 2012 May 23. Lancet. 2012. PMID: 22632908 Free PMC article. Clinical Trial.
Case for diagnosis.
Mesquita Lde S, Sherlock J, Portugal FM, Mota Lde S, Fakhouri R, Silva SF. Mesquita Lde S, et al. Among authors: sherlock j. An Bras Dermatol. 2014 Sep-Oct;89(5):841-2. doi: 10.1590/abd1806-4841.20143195. An Bras Dermatol. 2014. PMID: 25184935 Free PMC article.
Preliminary model assessing the cost-effectiveness of preoperative chlorhexidine mouthwash at reducing postoperative pneumonia among abdominal surgery patients in South Africa.
Kachapila M, Ademuyiwa AO, Biccard BM, Ghosh DN, Glasbey J, Monahan M, Moore R, Morton DG, Oppong R, Pearse R, Roberts TE; NIHR Global Health Research Unit on Global Surgery; ASOS Investigators; STARSurg Collaborative. Kachapila M, et al. PLoS One. 2021 Aug 12;16(8):e0254698. doi: 10.1371/journal.pone.0254698. eCollection 2021. PLoS One. 2021. PMID: 34383776 Free PMC article.
220 results